[go: up one dir, main page]

PE20081574A1 - DERIVADOS DE INDOL-2-IL-CARBONIL-PIPERIDINA COMO ANTAGONISTAS DEL RECEPTOR DE LA V1a - Google Patents

DERIVADOS DE INDOL-2-IL-CARBONIL-PIPERIDINA COMO ANTAGONISTAS DEL RECEPTOR DE LA V1a

Info

Publication number
PE20081574A1
PE20081574A1 PE2007001747A PE2007001747A PE20081574A1 PE 20081574 A1 PE20081574 A1 PE 20081574A1 PE 2007001747 A PE2007001747 A PE 2007001747A PE 2007001747 A PE2007001747 A PE 2007001747A PE 20081574 A1 PE20081574 A1 PE 20081574A1
Authority
PE
Peru
Prior art keywords
indol
carbonyl
alkyl
antagonists
receptor
Prior art date
Application number
PE2007001747A
Other languages
English (en)
Inventor
Caterina Bissantz
Christophe Grundschober
Raffaello Masciadri
Hasane Ratni
Mark Rogers-Evans
Patrick Schnider
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39272414&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20081574(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20081574A1 publication Critical patent/PE20081574A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE INDOL-2-IL-CARBONIL-PIPERIDINA DE FORMULA (I), EN DONDE A ES UN GRUPO (a), ENTRE OTROS X ES C=O e Y ES NR7, O X ES CH2 e Y ES O; O XES CH2 e Y ES CH2; R1 ES H; ALQUILO(C1-C6) OPCIONALMENTE SUSTITUIDO; R2 ES H, ALQUILO(C1-C6), ALCOXI(C1-C6), ALQUILENO(C1-C6)-NRcRd, ENTRE OTROS; R3 ES H, ALQUILO(C1-C6); R4 ES H, HALOGENO, ENTRE OTROS; R5 ES H, HALOGENO, ALQUILO(C1-C6), ENTRE OTROS; O R4 Y R5 ESTAN UNIDOS CON EL RESTO BENZO FORMANDO UN ANILLO Y SON -O-(CH2)n-O-; R6 ES H, ALQUILO(C1-C6) OPCIONALMENTE SUSTITUIDO, ALQUILENO(C1-C6)-C(O)-NRiRj, ENTRE OTROS. SON SELECCIONADOS: {5-CLORO-2-[4-(2-OXO-2,3-DIHIDRO-BENZOOXAZOL-7-IL)-PIPERIDINA-1-CARBONIL]-1H-INDOL-7-IL}-ACETONITRILO, 7-[1-(5-CLORO-7-MORFOLIN-4-ILMETIL-1H-INDOL-2-CARBONIL)-PIPERIDIN-4-IL]-3H-BENZOOXAZOL-2-ONA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON ANTAGONISTAS DEL RECEPTOR DE LA V1a, SIENDO UTILES EN EL TRATAMIENTO DE ANSIEDAD, TRASTORNOS DEPRESIVOS Y OTRAS ENFERMEDADES RELACIONADAS
PE2007001747A 2006-12-08 2007-12-07 DERIVADOS DE INDOL-2-IL-CARBONIL-PIPERIDINA COMO ANTAGONISTAS DEL RECEPTOR DE LA V1a PE20081574A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06125666 2006-12-08

Publications (1)

Publication Number Publication Date
PE20081574A1 true PE20081574A1 (es) 2008-11-22

Family

ID=39272414

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001747A PE20081574A1 (es) 2006-12-08 2007-12-07 DERIVADOS DE INDOL-2-IL-CARBONIL-PIPERIDINA COMO ANTAGONISTAS DEL RECEPTOR DE LA V1a

Country Status (19)

Country Link
US (3) US20080139552A1 (es)
EP (1) EP2102186B1 (es)
JP (1) JP2010511659A (es)
KR (2) KR20090078367A (es)
CN (1) CN101547914A (es)
AR (1) AR064138A1 (es)
AT (1) ATE527249T1 (es)
AU (1) AU2007328993B2 (es)
BR (1) BRPI0720440A2 (es)
CA (1) CA2670139A1 (es)
CL (1) CL2007003504A1 (es)
ES (1) ES2371784T3 (es)
IL (1) IL198633A0 (es)
MX (1) MX2009005544A (es)
NO (1) NO20091831L (es)
PE (1) PE20081574A1 (es)
RU (1) RU2009120136A (es)
TW (1) TWI349667B (es)
WO (1) WO2008068183A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2642998B1 (en) 2010-11-24 2020-09-16 The Trustees of Columbia University in the City of New York A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
WO2013166037A1 (en) 2012-05-01 2013-11-07 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of eye disorders
WO2014151959A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
EP2968303B1 (en) 2013-03-14 2018-07-04 The Trustees of Columbia University in the City of New York Octahydrocyclopentapyrroles, their preparation and use
WO2014152013A1 (en) * 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York 4-phenylpiperidines, their preparation and use
WO2014151936A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles, their preparation and use
AU2015253232B2 (en) 2014-04-30 2020-10-01 The Trustees Of Columbia University In The City Of New York Substituted 4-phenylpiperidines, their preparation and use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5150201A1 (es) 1998-09-07 2002-04-29 Hoffmann La Roche Derivados de piperidina
IL152177A0 (en) 2000-05-12 2003-05-29 Solvay Pharm Bv Piperazine and piperidine compounds
HU227197B1 (en) * 2000-10-24 2010-10-28 Richter Gedeon Nyrt Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them
WO2004035549A1 (en) 2002-10-17 2004-04-29 Amgen Inc. Benzimidazole derivatives and their use as vanilloid receptor ligands
JP2009513513A (ja) * 2003-07-04 2009-04-02 グラクソスミスクライン・ソシエタ・ペル・アチオニ Ｏｒｌ−１受容体リガンドとしての置換インドール
KR101020351B1 (ko) * 2005-07-29 2011-03-08 에프. 호프만-라 로슈 아게 인돌-3-일-카본일-피페리딘 및 피페라진 유도체
WO2008068184A1 (en) * 2006-12-08 2008-06-12 F. Hoffmann-La Roche Ag Indoles which act as via receptor antagonists

Also Published As

Publication number Publication date
ES2371784T3 (es) 2012-01-10
WO2008068183A1 (en) 2008-06-12
EP2102186B1 (en) 2011-10-05
TW200831502A (en) 2008-08-01
RU2009120136A (ru) 2011-01-20
KR20090078367A (ko) 2009-07-17
US20080139549A1 (en) 2008-06-12
IL198633A0 (en) 2010-02-17
ATE527249T1 (de) 2011-10-15
NO20091831L (no) 2009-07-07
BRPI0720440A2 (pt) 2014-01-07
CL2007003504A1 (es) 2008-07-04
AR064138A1 (es) 2009-03-18
CN101547914A (zh) 2009-09-30
US20080139550A1 (en) 2008-06-12
AU2007328993B2 (en) 2012-05-10
AU2007328993A1 (en) 2008-06-12
US20080139552A1 (en) 2008-06-12
KR20120055716A (ko) 2012-05-31
EP2102186A1 (en) 2009-09-23
US8026259B2 (en) 2011-09-27
JP2010511659A (ja) 2010-04-15
TWI349667B (en) 2011-10-01
CA2670139A1 (en) 2008-06-12
US8076360B2 (en) 2011-12-13
MX2009005544A (es) 2009-06-05

Similar Documents

Publication Publication Date Title
PE20081574A1 (es) DERIVADOS DE INDOL-2-IL-CARBONIL-PIPERIDINA COMO ANTAGONISTAS DEL RECEPTOR DE LA V1a
PE20120031A1 (es) Compuestos aril metil benzoquinazolinona como moduladores alostericos positivos del receptor m1
PE20091173A1 (es) Derivados de heteroarilo como antagonistas de receptor de orexina
PE20050525A1 (es) Derivados de pirazol sustituido y compuestos relacionados como antagonistas del receptor de bradiquinina b1
PE20081238A1 (es) Piperidinas sustituidas como antagonistas de hdm2
PE20090775A1 (es) Nuevos derivados de biarilo
PE20080404A1 (es) Derivados bencil-amino-piperidina como inhibidores de cetp
PE20081152A1 (es) Azaciclilaminas n-sustituidas como antagonistas de histamina-3
PE20121158A1 (es) Derivados de feniletinilo como moduladores alostericos positivos (map)
PE20091429A1 (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas como inhibidores de la elastasa neutrofila humana (hne)
PE20160216A1 (es) ENANTIOMERO (S) DE 1'-{[5-(TRIFLUOROMETIL)FURAN-2-IL]METIL}ESPIRO[FURO[2,3-f][1,3]BENZODIOXOL-7-3'-INDOL]-2'(1'H)-ONA
PE20071152A1 (es) Compuestos derivados de azabiciclo[3.1.0]hex como moduladores de receptores de dopamina d3
PE20091090A1 (es) Derivados de piperidina como agonistas de receptores muscarinicos
PE20121640A1 (es) Derivados de pirazina como inhibidores de bace
PE20160691A1 (es) Nuevos derivados de triazolo[4,5-d]pirimidina
PE20091353A1 (es) Nuevos compuestos heterociclicos
PE20090546A1 (es) Derivados de imidazol como antagonistas de los receptores de quimioquina ccr-2, ccr-3 y ccr-5
AR067662A1 (es) Derivados de benzo[d]isoxazol-3-il-piperidina, medicamentos que los contienen y usos terapeuticos para enfermedades asociadas al sistema nervioso.
PE20180500A1 (es) Derivados de 2,3-dihidro-4h-1,3-benzoxazin-4-ona como moduladores del receptor muscarinico colinergico m1
PE20080405A1 (es) COMPUESTOS Y COMPOSICIONES COMO INHIBIDORES DE ITPKb
PE20071156A1 (es) COMPUESTOS DERIVADOS DE 4,5,6,7-TETRAHIDRO-1H-INDAZOL COMO POTENCIADORES DEL RECEPTOR DEL ACIDO a-AMINO-3-HIDROXI-5-METILISOXAZOL-4-PROPIONICO (AMPA)
PE20120593A1 (es) Derivados fusionados de pirimidin-4-ona como antagonistas del receptor de angiotensina ii y como agonistas del receptor ppar gamma
PE20110703A1 (es) Acidos naftilaceticos
AR070797A1 (es) Derivados de quinoxalinona como estimulantes de la secrecion de insulina, metodos para obtenerlos y su uso en el tratamiento de la diabetes
PE20090622A1 (es) Nuevos derivados de bencimidazol sustituido

Legal Events

Date Code Title Description
FC Refusal